Table 1.
Overview comparing myotonic dystrophies with selected nuclear envelope- and DNA repair- linked progeroid syndromes.
| Disease | Type | Gene | Age of onset | Age of death | Skin | Bones | Eyes | Muscle /Fat | Developmental delay | Neuro-degeneration | Diabetes mellitus | Hair | Cancer |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Myotonic Dystrophy type 1 (DM1) | Mild | DMPK | 20–70 yrs | 60 yrs–normal | dysplastic nevi, alopecia, xerosis and seborrheic dermatitis | cataracts | myotonia | no | diabetes mellitus | alopecia | possibly increased risk | ||
| Classic | 10–30 yrs | 48–55 yrs | dysplastic nevi, alopecia, xerosis and seborrheic dermatitis | cataracts | myotonia, muscular dystrophy | no | axonal peripheral neuropathy, CNS involvment | diabetes mellitus | alopecia | possibly increased risk | |||
| Congenital | Birth to 10 yrs | Neonatal / 45 yrs | dysplastic nevi, alopecia, xerosis and seborrheic dermatitis | cataracts | muscular dystrophy | yes | yes | diabetes mellitus | possibly increased risk | ||||
| Myotonic Dystrophy type 2 (DM2) | CNBP | 3rd decade | Sudden death due to cardiac involvement possible | dysplastic nevi, alopecia, xerosis and seborrheic dermatitis | cataracts | myotonia, muscular dystrophy | no | in a few cases | diabetes mellitus | rarely alopecia | possibly increased risk | ||
| Hutchinson-Gilford progeria syndrome (HGPS) | LMNA | 1–2 yrs | 14 yrs | scleroderma-like | osteolysis | no | partial lipodystrophy | yes | no | diabetes mellitus | loss | no increased risk | |
| Mandibuloacral dysplasia (MAD) | MADA | LMNA | 4-5 yrs | normal life expectancy | skin atrophy, calcinosis | osteolysis | no | partial lipodystrophy | yes | no | diabetes mellitus | alopecia | no increased risk |
| MADB | ZMPSTE24 | 2 yrs | skin atrophy | osteolysis | no | generalized lipodystrophy | yes | no | diabetes mellitus | alopecia | no increased risk | ||
| Restrictive dermopathy (RD) | ZMPSTE24 | Antenatal, Neonatal | mean age of 13.5 years | hyperkeratosis | hypertelorism, entropion | no | yes | absent/spare eyebrows, -lashes, lanugo | no increased risk | ||||
| Malouf syndrome | LMNA | Infancy, neonatal | 18-26 yrs | no | osteoporosis | ptosis | lipodystrophy | no | mental retardation (some patients) | no | no | no increased risk | |
| Nestor-Guillermo progeria syndrome (NGPS) | BANF1 | 2 yrs | Third decade of life | dry, atrophic | osteoporosis, osteolysis | propotosis | generalized lipoatrophy | yes | no | no | loss | no increased risk | |
| Werner syndrome | WRN | Median age 13 yrs | Median age of 54 | scleroderma-like | osteoporosis | cataracts | Muscle atrophy | yes | brain atrophy in 40% | diabetes mellitus | loss, premature greying | increased risk | |
| Bloom syndrome | BLM | birth | Median age 27 | photosensitivity, pigmentation abnormalities | no | no | no | yes | mild retardation, learning disability (some patients) | non-insulin-dependent diabetes mellitus | hypertrichosis | increased risk | |
| Cockayne syndrome (CS) | CSA | ERCC8 | 1 yr | 12 yrs | photosensivity, wrikeled and premature aged | cataracts, pigmentary retinopathy | denervation myopathy | yes | intellectual disability | diabetes mellitus | thin, dry and premature greying | no increased risk | |
| CSB | ERCC6 | birth | 7 yrs | severe mental retardation |